Journal ArticleOPEN ACCESS

Comparative analysis of the efficacy and safety of modified FOLFOX-6 and DCF regimens as first-line treatment in advanced gastric cancer

  • HACIBEKIROGLU I
  • KODAZ H
  • ERDOGAN B
  • et al.
Molecular and Clinical Oncology (2015) 3(5) 1160-1164
DOI: 10.3892/mco.2015.592
N/ACitations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Introduction Gastric cancer is one of the most common causes of cancer-related mortality worldwide (1). Despite the decline in incidence and mortality rates over the last two decades, >40% of [...]

Cite

CITATION STYLE

APA

HACIBEKIROGLU, I., KODAZ, H., ERDOGAN, B., TURKMEN, E., ESENKAYA, A., ONAL, Y., … CICIN, I. (2015). Comparative analysis of the efficacy and safety of modified FOLFOX-6 and DCF regimens as first-line treatment in advanced gastric cancer. Molecular and Clinical Oncology, 3(5), 1160–1164. https://doi.org/10.3892/mco.2015.592

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free